| The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota J Boursier, O Mueller, M Barret, M Machado, L Fizanne, F Araujo‐Perez, ... Hepatology 63 (3), 764-775, 2016 | 1291 | 2016 |
| Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ... Gastroenterology 150 (5), 1147-1159. e5, 2016 | 1106 | 2016 |
| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 1094 | 2023 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1045 | 2019 |
| EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version) CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ... Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017 | 970 | 2017 |
| EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update CPG Panel, A Berzigotti, E Tsochatzis, J Boursier, L Castera, N Cazzagon, ... Journal of hepatology 75 (3), 659-689, 2021 | 654 | 2021 |
| Determination of reliability criteria for liver stiffness evaluation by transient elastography J Boursier, JP Zarski, V de Ledinghen, MC Rousselet, N Sturm, B Lebail, ... Hepatology 57 (3), 1182-1191, 2013 | 596 | 2013 |
| Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy C Cassinotto, J Boursier, V de Lédinghen, J Lebigot, B Lapuyade, ... Hepatology 63 (6), 1817-1827, 2016 | 539 | 2016 |
| FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation … PN Newsome, M Sasso, JJ Deeks, A Paredes, J Boursier, WK Chan, ... The lancet Gastroenterology & hepatology 5 (4), 362-373, 2020 | 529 | 2020 |
| A placebo-controlled trial of bezafibrate in primary biliary cholangitis C Corpechot, O Chazouillères, A Rousseau, A Le Gruyer, F Habersetzer, ... New England Journal of Medicine 378 (23), 2171-2181, 2018 | 485 | 2018 |
| Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease J Boursier, J Vergniol, A Guillet, JB Hiriart, A Lannes, B Le Bail, ... Journal of hepatology 65 (3), 570-578, 2016 | 400 | 2016 |
| Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease MV Machado, GA Michelotti, G Xie, TP de Almeida, J Boursier, B Bohnic, ... PloS one 10 (5), e0127991, 2015 | 390 | 2015 |
| Comparison of blood tests for liver fibrosis specific or not to NAFLD P Calès, F Lainé, J Boursier, Y Deugnier, V Moal, F Oberti, G Hunault, ... Journal of hepatology 50 (1), 165-173, 2009 | 335 | 2009 |
| Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal, M Trauner, J Boursier, ... Gut 71 (5), 1006-1019, 2022 | 277 | 2022 |
| Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial P Mathurin, A Louvet, A Duhamel, P Nahon, N Carbonell, J Boursier, ... Jama 310 (10), 1033-1041, 2013 | 256 | 2013 |
| Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: a systematic review J Lee, Y Vali, J Boursier, R Spijker, QM Anstee, PM Bossuyt, ... Liver international 41 (2), 261-270, 2021 | 221 | 2021 |
| Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis O Govaere, S Cockell, D Tiniakos, R Queen, R Younes, M Vacca, ... Science translational medicine 12 (572), eaba4448, 2020 | 221 | 2020 |
| Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis Y Vali, J Lee, J Boursier, R Spijker, J Löffler, J Verheij, MJ Brosnan, ... Journal of hepatology 73 (2), 252-262, 2020 | 210 | 2020 |
| Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 196 | 2021 |
| Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis A Louvet, J Labreuche, F Artru, J Boursier, DJ Kim, J O’Grady, E Trépo, ... Gastroenterology 149 (2), 398-406. e8, 2015 | 195 | 2015 |
